Journal
/
/
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Journal JoVE
Recherche en cancérologie
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Recherche en cancérologie
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
DOI:

08:59 min

December 11, 2017

, , , , , ,

Chapitres

  • 00:05Titre
  • 01:39Generation of Targeted Therapy Resistant Subclones
  • 04:03Restoring Target-therapy Inhibitor Sensitivity by Candidate R-gene Knock-down
  • 06:31Results: Drug Resistant Subclone Generation and Sensitivity Restoration
  • 08:01Conclusion

Summary

Traduction automatique

This is a time- and cost-effective in vitro protocol investigating the mechanisms of acquired resistance to targeted therapeutic agents, which is a highly unmet medical need in cancer management.

Vidéos Connexes

Read Article